Cargando…
Nanotechnology and COVID-19: quo vadis?
The pandemic COVID-19 has worried everyone due to the high mortality rate and the high number of people hospitalized with severe acute respiratory syndrome caused by SARS-CoV-2. Given the seriousness of this disease, several companies and research institutions have sought alternative treatment and/o...
Autores principales: | Tavares, João Lima, Cavalcanti, Iago Dillion Lima, Santos Magalhães, Nereide Stela, Lira Nogueira, Mariane Cajubá de Britto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901091/ https://www.ncbi.nlm.nih.gov/pubmed/35283662 http://dx.doi.org/10.1007/s11051-022-05452-0 |
Ejemplares similares
-
Pharmaceutical nanotechnology: which products are been designed against COVID-19?
por: Cavalcanti, Iago Dillion Lima, et al.
Publicado: (2020) -
Rheumatologie – quo vadis? Gesundheitssystem – quo vadis?
por: Puchner, Rudolf
Publicado: (2023) -
Quo vadis?
por: Sienkiewicz, Henryk, 1846-1916
Publicado: (1943) -
“Quo Vadis?”
por: Bereen, J. F.
Publicado: (1964) -
Quo vadis? /
por: Sienkiewicz, Henryk, 1846-1916